Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	35
ISBN Number	not applicable
Product Code	GMD04786

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Cyberkinetics Neurotechnology Systems, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 History
5 Competitors
6 Key Employees
7 Key Employee Biographies
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Recent Developments
- 10.1 Financial Announcements
  - 10.1.1 Nov 14, 2007: Cyberkinetics Declares Q3 2007 Results
  - 10.1.2 Aug 09, 2007: Cyberkinetics Reports Q2 2007 Results
  - 10.1.3 May 10, 2007: Cyberkinetics Reports Q1 2007 Results
  - 10.1.4 Dec 31, 2006: Cyberkinetics Reports Q4 2006 Results
  - 10.1.5 Nov 08, 2006: Cyberkinetics Reports Q3 2006 Results
- 10.2 Corporate Communications
  - 10.2.1 Sep 19, 2006: Cyberkinetics Appoints New CFO
- 10.3 Product News
  - 10.3.1 Mar 03, 2008: Cyberkinetics Andara OFS Therapy Featured In Presentations at the AANS/CNS Meeting
  - 10.3.2 Dec 11, 2007: Cyberkinetics Receives FDA Response Letter On Andara OFS System For Acute Spinal Cord Injury
  - 10.3.3 Apr 11, 2007: United States Patent And Trademark Office Issues Cyberkinetics Patent For Andara OFS Therapy
  - 10.3.4 Feb 20, 2007: Cyberkinetics Files To Market Andara OFS Therapy For Acute Spinal Cord Injury Under Humanitarian Device Exemption
11 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products
- 11.1 Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis
  - 11.1.1 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Equipment Type
  - 11.1.2 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage
  - 11.1.3 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Therapy Area
  - 11.1.4 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical Trials
  - 11.1.5 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary
- 11.2 Andara Oscillating Field Stimulator system
  - 11.2.1 Product Description
  - 11.2.2 Product Status
  - 11.2.3 Clinical Trials
  - 11.2.4 Product Milestone
- 11.3 Andara OFS Plus
  - 11.3.1 Product Description
  - 11.3.2 Product Status
- 11.4 BrainGate Neural Interface System
  - 11.4.1 Product Description
  - 11.4.2 Product Status
  - 11.4.3 Clinical Trials
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
1 List of Tables
- Table 1: Cyberkinetics Neurotechnology Systems, Inc.,Key Facts
- Table 2: Cyberkinetics Neurotechnology Systems, Inc., Key Employees,
- Table 3: Cyberkinetics Neurotechnology Systems, Inc., Other Locations
- Table 4: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products by Equipment Type
- Table 5: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage
- Table 6: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Therapy Area
- Table 7: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical Trials
- Table 8: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage
- Figure 2: Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary
- Figure 3: Global Markets Direct Methodology